Case Commentary: An espresso, a free puppy, and multidrug-resistant Campylobacter
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.00752-23 ↗Kurz gefasst
Kommentar in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von William L Musick. Beteiligte Einrichtung: Houston Methodist Hospital , Houston, Texas, USA. Hauptthemen laut MEDLINE: Campylobacter, Campylobacter coli, Campylobacter jejuni, Campylobacter Infections. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Campylobacter species infections in immunocompromised patients have the potential to progress to bacteremia and other extra-intestinal diseases. There is a sparsity of robust data, including antibiotic susceptibility data for contemporary agents, upon which to base treatment decisions. Moreover, intrinsic antimicrobial resistance in Campylobacter spp. further limits treatment options. The current publication by Bonilla-Moreno et al. elaborates on this clinical dilemma through the development, treatment, and molecular investigation of the putative mechanisms of carbapenem resistance in an immunocompromised patient with Campylobacter coli bacteremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Houston Methodist Hospital , Houston, Texas, USA.
ORCID-Profile: William L Musick
Zitieren
APA
Musick, W. L. (2023). Case Commentary: An espresso, a free puppy, and multidrug-resistant Campylobacter. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00752-23
Vancouver
Musick WL. Case Commentary: An espresso, a free puppy, and multidrug-resistant Campylobacter. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00752-23
BibTeX
@article{Musick2023,
author = {Musick, William L},
title = {Case Commentary: An espresso, a free puppy, and multidrug-resistant Campylobacter},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.00752-23}
}
EUVIMED